Senior Advisor, Regulatory Starting Materials Strategy

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is seeking a Senior Advisor, Regulatory Starting Material to lead the strategy, justification, and regulatory positioning of Regulatory Starting Materials for drug substance manufacturing processes supporting late-stage clinical and commercial programs. Reporting to the VP, CMC, this role serves as the SME on RSM selection, ensuring GMP routes and supply strategies are regulatorily defensible.